To the best of our knowledge, this is the first analysis of the association between changes in albumin-adjusted serum calcium levels and the risk of LVH that focused specifically on T2DM patients with normocalcemia and normophosphatemia. This evidence concerns the gene ALB and type 2 diabetes mellitus.